SG11201700537VA - Compounds against ralstonia pickettii for use in the treatment of insulin resistance, and method of diagnosis of insulin resistance - Google Patents
Compounds against ralstonia pickettii for use in the treatment of insulin resistance, and method of diagnosis of insulin resistanceInfo
- Publication number
- SG11201700537VA SG11201700537VA SG11201700537VA SG11201700537VA SG11201700537VA SG 11201700537V A SG11201700537V A SG 11201700537VA SG 11201700537V A SG11201700537V A SG 11201700537VA SG 11201700537V A SG11201700537V A SG 11201700537VA SG 11201700537V A SG11201700537V A SG 11201700537VA
- Authority
- SG
- Singapore
- Prior art keywords
- insulin resistance
- diagnosis
- treatment
- compounds against
- ralstonia pickettii
- Prior art date
Links
- 206010022489 Insulin Resistance Diseases 0.000 title 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title 2
- 241000589625 Ralstonia pickettii Species 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0208—Specific bacteria not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Obesity (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14182707 | 2014-08-28 | ||
| PCT/EP2015/069733 WO2016030500A2 (en) | 2014-08-28 | 2015-08-28 | Compounds against ralstonia pickettii for use in the treatment of insulin resistance, and method of diagnosis of insulin resistance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201700537VA true SG11201700537VA (en) | 2017-03-30 |
Family
ID=51421913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201700537VA SG11201700537VA (en) | 2014-08-28 | 2015-08-28 | Compounds against ralstonia pickettii for use in the treatment of insulin resistance, and method of diagnosis of insulin resistance |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20170252421A1 (en) |
| EP (1) | EP3185894A2 (en) |
| KR (1) | KR20170043538A (en) |
| CN (1) | CN106999560A (en) |
| AU (1) | AU2015308403A1 (en) |
| BR (1) | BR112017003778A2 (en) |
| CA (1) | CA2956047A1 (en) |
| RU (1) | RU2017102997A (en) |
| SG (1) | SG11201700537VA (en) |
| WO (1) | WO2016030500A2 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202106694YA (en) * | 2019-01-23 | 2021-07-29 | Glycolysis Biomed Co Ltd | Beta-lactam compounds or salts thereof for use in long-acting prevention or treatment of a glucose metabolism disorder |
| CN113679725A (en) * | 2020-11-30 | 2021-11-23 | 兰州大学 | Cephalosporin compound and application thereof in preparation of drugs for treating diabetes and complications |
| JP2024033027A (en) * | 2021-01-22 | 2024-03-13 | 国立研究開発法人産業技術総合研究所 | Bacteriophages that infect diabetes-inducing bacteria and their uses |
| WO2022182329A1 (en) * | 2021-02-23 | 2022-09-01 | Adaptive Phage Therapeutics, Inc. | Phage therapy of gut microbiota dysbiosis, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis |
| CN113080114A (en) * | 2021-04-12 | 2021-07-09 | 浙江大学 | Method for increasing survival rate of fish offspring |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3862313A (en) | 1974-01-17 | 1975-01-21 | Us Interior | Vibrio vaccine and immunization |
| US4298597A (en) | 1979-09-04 | 1981-11-03 | University Of Saskatchewan | Vaccine for diarrhea caused by E. coli |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US4707543A (en) | 1985-09-17 | 1987-11-17 | The United States Of America As Represented By The Secretary Of The Army | Process for the preparation of detoxified polysaccharide-outer membrane protein complexes, and their use as antibacterial vaccines |
| WO2012131099A1 (en) * | 2011-03-31 | 2012-10-04 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Use of blood or tissue bacteriome for prediction, diagnosis and prevention of metabolic diseases and their cardiovascular complications |
| CN102978132B (en) * | 2012-11-19 | 2015-04-15 | 南京农业大学 | Microorganism plant vaccine capable of controlling tomato bacterial wilt disease |
| CN103704069A (en) * | 2013-12-11 | 2014-04-09 | 南京农业大学 | Method of three-dimensionally preventing and controlling tomato bacterial wilt |
-
2015
- 2015-08-28 KR KR1020177004574A patent/KR20170043538A/en unknown
- 2015-08-28 BR BR112017003778A patent/BR112017003778A2/en not_active Application Discontinuation
- 2015-08-28 AU AU2015308403A patent/AU2015308403A1/en not_active Abandoned
- 2015-08-28 CA CA2956047A patent/CA2956047A1/en not_active Abandoned
- 2015-08-28 US US15/506,948 patent/US20170252421A1/en not_active Abandoned
- 2015-08-28 CN CN201580046098.7A patent/CN106999560A/en not_active Withdrawn
- 2015-08-28 WO PCT/EP2015/069733 patent/WO2016030500A2/en active Application Filing
- 2015-08-28 SG SG11201700537VA patent/SG11201700537VA/en unknown
- 2015-08-28 RU RU2017102997A patent/RU2017102997A/en not_active Application Discontinuation
- 2015-08-28 EP EP15756644.9A patent/EP3185894A2/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CN106999560A (en) | 2017-08-01 |
| RU2017102997A (en) | 2018-09-28 |
| CA2956047A1 (en) | 2016-03-03 |
| KR20170043538A (en) | 2017-04-21 |
| US20170252421A1 (en) | 2017-09-07 |
| BR112017003778A2 (en) | 2017-12-12 |
| AU2015308403A1 (en) | 2017-02-16 |
| WO2016030500A2 (en) | 2016-03-03 |
| WO2016030500A3 (en) | 2016-04-21 |
| EP3185894A2 (en) | 2017-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1221044A1 (en) | Treatment apparatus with medical feature activation | |
| HRP20180631T1 (en) | Mini-gastrin analogue, in particular for use in cck2 receptor positive tumour diagnosis and/or treatment | |
| HK1222778A1 (en) | Medical device, and the methods of using same | |
| IL246757A0 (en) | Novel insulin derivatives and the medical uses hereof | |
| HK1245299A1 (en) | Blood brain barrier transport molecules and uses thereof | |
| ZA201603206B (en) | Fluid treatment apparatus and process | |
| EP3155971A4 (en) | Medical diagnostic device, medical diagnostic device operation method, and medical diagnostic device operation program | |
| IL283335B (en) | Dihydropyrimidin-2-one compounds and medical use thereof | |
| HK1243055A1 (en) | Compounds for use in anthelminthic treatment | |
| GB201413357D0 (en) | Antibodies for treatment and diagnosis | |
| SG11201700537VA (en) | Compounds against ralstonia pickettii for use in the treatment of insulin resistance, and method of diagnosis of insulin resistance | |
| EP3200118A4 (en) | Sample traceability device and method for medical research and/or diagnosis | |
| IL250692B (en) | Medical treatments based on anamorelin | |
| ZA201701426B (en) | Compounds for use in anthelminthic treatment | |
| SG11201700623YA (en) | Biological treatment method and biological treatment device | |
| PL3232998T3 (en) | Medical device for performing ileostomies and/or jejunostomies | |
| GB201500875D0 (en) | Antibodies for treatment and diagnosis | |
| PL3015109T3 (en) | Biological barrier with simethicone for the use in the treatment of naso-pharyngo-tubal infections | |
| GB201418541D0 (en) | Materials for use with general hyperthermia treatment | |
| GB201401806D0 (en) | Novel methods for diagnosis and therapy | |
| PL3334479T3 (en) | Blood treatment device | |
| GB201501202D0 (en) | Novel methods for diagnosis and therapy | |
| ZA201404780B (en) | Composition for use in treatment of diabetes |